First-in-class anti-PVR mAb NTX1088 restores DNAM1 expression and enhances antitumor immunity

A. Atieh; A. Obiedat; A. Vitenshtein; G. Cinamon; K. Paz; T. Roviš; P. Kucan; L. Hirsl; O. Mandelboim; S. Jonjic; T. Pini

doi:10.1016/S0959-8049(22)00987-X

First-in-class anti-PVR mAb NTX1088 restores DNAM1 expression and enhances antitumor immunity

A. Atieh, A. Obiedat, A. Vitenshtein, G. Cinamon, K. Paz, T. Roviš, P. Kucan, L. Hirsl, O. Mandelboim, S. Jonjic, T. Pini

Department of Immunology and Cancer Research

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S69-S70
Journal	European Journal of Cancer
Volume	174
DOIs	https://doi.org/10.1016/S0959-8049(22)00987-X
State	Published - Oct 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0959-8049(22)00987-X

Cite this

@article{c578b4e45d824700a14f08af7b9a1aed,

title = "First-in-class anti-PVR mAb NTX1088 restores DNAM1 expression and enhances antitumor immunity",

author = "A. Atieh and A. Obiedat and A. Vitenshtein and G. Cinamon and K. Paz and T. Rovi{\v s} and P. Kucan and L. Hirsl and O. Mandelboim and S. Jonjic and T. Pini",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)00987-X",

language = "אנגלית",

volume = "174",

pages = "S69--S70",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - First-in-class anti-PVR mAb NTX1088 restores DNAM1 expression and enhances antitumor immunity

AU - Atieh, A.

AU - Obiedat, A.

AU - Vitenshtein, A.

AU - Cinamon, G.

AU - Paz, K.

AU - Roviš, T.

AU - Kucan, P.

AU - Hirsl, L.

AU - Mandelboim, O.

AU - Jonjic, S.

AU - Pini, T.

PY - 2022/10

Y1 - 2022/10

UR - http://www.scopus.com/inward/record.url?scp=85143780687&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(22)00987-X

DO - 10.1016/S0959-8049(22)00987-X

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:85143780687

SN - 0959-8049

VL - 174

SP - S69-S70

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

First-in-class anti-PVR mAb NTX1088 restores DNAM1 expression and enhances antitumor immunity

UN SDGs

Access to Document

Other files and links

Cite this